The country's medicine regulator has asked for more information from pharmaceutical company Janssen before making a decision to approve its Covid-19 vaccine.
The US, European Union and South Africa have temporarily halted the rollout of the company's Covid jab due to fears over rare blood clots, the BBC reported this week.
The US Centres for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) are reviewing data involving six reported cases in the States of a rare and severe blood clot in people who had received the vaccine.
The agencies said the events of blood clots appeared to be extremely rare.